Woodford Investment Management as of June 30, 2017
Portfolio Holdings for Woodford Investment Management
Woodford Investment Management holds 7 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 31.6 | $860M | 12M | 72.51 | |
| Prothena (PRTA) | 22.7 | $617M | 11M | 54.12 | |
| Alkermes (ALKS) | 16.3 | $443M | 7.6M | 57.97 | |
| Theravance Biopharma (TBPH) | 15.7 | $427M | 11M | 39.84 | |
| Gilead Sciences (GILD) | 5.8 | $157M | 2.2M | 70.78 | |
| Bioverativ Inc Com equity | 4.4 | $119M | 2.0M | 60.17 | |
| Biogen Idec (BIIB) | 3.7 | $100M | 369k | 271.36 |
